◆ 会议时间：2024年4月10-14日
◆ 会议地点：美国 奥兰多

◆ 会议简介：

2024年第25届美国乳腺外科医师学会年会将于2024年4月10-14日在美国奥兰多举行。会议将以科学报告、商业展览和互动交流为特色，预计将有超过1700名医学专业人士与会，包括普通外科医生、外科肿瘤学家、整形外科医生、放射科医生、肿瘤内科医生和相关健康专业人士等等。

美国乳腺外科医师学会成立于1995年，是从事乳腺疾病治疗的普通外科医生的主要领导组织，现在世界各地拥有超过3000名成员；学会致力于通过提供一个交流思想以及促进教育、研究和先进外科技术发展宣的论坛，为乳腺外科医生提供支持，不断改进乳腺外科实践。学会的年度会议是乳腺外科界的首要教育科学活动。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

ASBrS 2024 - 25th Annual Meeting of the American Society of Breast Surgeons

DATE: April 10–14, 2024
VENUE: Marriott Orlando World Center, Orlando, Florida, USA

摘要征文投稿：

Call for Abstracts

Deadline: November 8, 2023, 3PM ET

点此提交摘要>>>Submit Abstract>>>

提交费：

All abstract submissions are subject to a non-refundable $60 submission fee.

Overall Instructions for Abstracts

• Abstracts may not contain data that have been previously presented or will be presented or published prior to the 2024 Annual Meeting.
• All abstracts for the 2024 Annual Meeting must be submitted through our online submission portal.
• Institutional names are not to be included anywhere in the title or body of the abstract.
• Case reports will not be accepted.
• Word limit – 500 words or less. Word limit does not include title or authors. Abstracts that exceed the word limit will not be accepted.
• Abstracts submitted may include 1 table OR 1 figure. Abstracts submitted with more than 1 table or 1 figure will not be accepted.
• All words must be those of the authors. Abstracts written by artificial intelligence (AI) will not be accepted.
• Disclosure Declaration: The ASBrS disclosure policy promotes balance, independence, objectivity, and scientific rigor in all of its educational activities through the disclosure of financial or non-financial/strategic business relationships or partnerships (relationships) and mitigation of relevant relationships. The relationships requiring disclosure are outlined in the ASBrS CME Activity Disclosure Policy. All authors are required to disclose all financial, and non-financial/strategic, business relationships or partnerships (relationships) with any ineligible company they have had over the past 24 months.
  • Ineligible Company: “A for‐profit entity that develops, produces, markets, or distributes drugs, devices, services or therapies used to diagnose, treat, monitor, manage, and alleviate health conditions. This definition is not intended to include non‐profit entities, entities outside of the healthcare sector, or entities through which physicians provide clinical services directly to patients.”
  • If the first presenting author is employed by an ineligible company as defined by the ACCME, an alternate presenter who does not have a relevant employment relationship must be named if the abstract is selected for presentation in an oral abstract session. Oral abstract presenters will also be subject to the same disclosure review and management strategies as faculty. The alternate presenter should not be financially motivated or interested in presenting the abstract.
  • Oral abstract presenters will also be subject to the disclosure review and mitigation process outlined in the 'CME Activity Disclosure Process for Financial or Non-financial/Strategic Business Relationships or Partnerships'.
    • Oral abstract presenters must disclose all financial, and non-financial/strategic, business relationships or partnerships (relationships) with any ineligible company they have had over the past 24 months.
    • Financial relationships of any dollar amount or non-financial/strategic business relationships or partnerships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.
    • Should it be determined that a relevant relationship exists, the individual will be contacted by a designated ASBrS official with methods to mitigate the relationship.
    • An advanced conflict mitigation process will be initiated if the designated ASBrS official determines a relevant relationship requires additional review. The CME committee will determine the applicable parties for additional review.
    • If the relevant relationship cannot be mitigated, an alternate presenter must be named and will be subject to the 'CME Activity Disclosure Process for Financial or Non-financial/Strategic Business Relationships or Partnerships'.
    • All relevant relationships must be mitigated before the start of the annual meeting.

视频提交：

Call for ‘How I Do It’ Videos

“A picture is worth a thousand words.” Certainly, for surgeons a video can often educate better than other formats. ASBrS is again inviting you to submit a video showing your colleagues your tricks of the trade. Your video can be used to demonstrate how you perform a novel procedure, provide tips or tricks you use on a standard procedure, or show an approach you take to a clinical problem.

Videos will be peer-reviewed by the Society's Online Video Library Committee, who will select the best submissions for presentation based on procedure, quality of technique and video, and interest to the Society membership. During the presentation session, the video will be played without sound and the author will be expected to present in person with live narration. The author of videos selected for presentation must be available to present their videos at the 25th Annual Meeting: April 10–14, 2024, at the Orlando Marriott World Center, Orlando, FL.

If you have any questions, please contact pbunn@breastsurgeons.org or call 877‑992‑5470 (M–F 8:30 am–5:00 pm et).

Click Here to submit a video.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。